Spruce Biosciences Stock (NASDAQ: SPRB) stock price, news, charts, stock research, profile.
Open | $0.680 |
Close | $0.701 |
Volume / Avg. | 379.744K / 1.339M |
Day Range | 0.680 - 0.710 |
52 Wk Range | 0.671 - 5.950 |
Market Cap | $28.840M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 0.82% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spruce Biosciences (NASDAQ: SPRB) through any online brokerage.
Other companies in Spruce Biosciences’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), T2 Biosystems (NASDAQ:TTOO) and Palatin Techs (AMEX:PTN).
The latest price target for Spruce Biosciences (NASDAQ: SPRB) was reported by RBC Capital on Thursday, March 14, 2024. The analyst firm set a price target for 2.00 expecting SPRB to rise to within 12 months (a possible 185.39% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $0.7008 last updated April 25, 2024 at 5:49 PM EDT.
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.